BEHANDLUNG VON PATIENTEN DIE EINE KNOCHENMARKTRANSPLANTATION ODER EINE TRANSPLANTATION PERIPHERER BLUTSTAMMZELLEN ERHALTEN MIT ANTI-CD20 ANTIKÖRPERN
European patent · EP1131096 · Deleted
Register entry
- Publication number
- EP1131096
- Application number
- EP99958649
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Nov 9, 1999
- Published
- Sep 12, 2001
- Granted
- Jan 6, 2010
- Deleted
- Nov 8, 2019
- Reason
- Maximum term reached
- IPC classes
- A61K 39/395 (2006.01)A61K 39/00 (2006.01)A61K 35/02 (2006.01)
- Priority
- US 107657 P 09.11.1998
- PCT application
- PCT/US1999/024012 09.11.1999
- PCT publication
- WO2000/027433 18.05.2000
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Nov 11, 2019
Maximum term reached
Published in Swissreg on 11.11.2019
- Jul 10, 2015
Address changed
- Owner
- Biogen Idec Inc., 14 Cambridge Center, Cambridge, MA 02142, USA → Biogen Inc., 225 Binney Street, Cambridge MA 02142, USA
Published in Swissreg on 10.07.2015
- Jan 6, 2010
Granted
Published in Swissreg on 06.01.2010
Parties
Inventor
GRILLO-LOPEZ, Antonio, J.
Rancho Santa Fe, CA 92067, US
LEONARD, John, E.
Carlsbad, CA 92009, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.